Lily Y. Koo, PhD U.S. FDA

Lily Koo is a biomedical engineer working in the Office of Director at FDA’s Center for Biologics Evaluation and Research (CBER). Previously, she worked as a Consumer Safety Officer in the Division of Manufacturing and Product Quality (DMPQ) in the Office of Compliance and Biologics Quality (OCBQ) in CBER where she was responsible for the review of facility and equipment information in license applications and supplements and conducted pre-license and pre-approval inspections of biologics manufacturing facilities. Prior to joining CBER, she worked at the Center for Device and Radiological Health and the National Institutes of Health. Lily received her B.S. in bioengineering from University of Pennsylvania and her Ph.D. in chemical engineering from Massachusetts Institute of Technology.